» Authors » Peter Bampton

Peter Bampton

Explore the profile of Peter Bampton including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 52
Citations 698
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Barnes A, Spizzo P, Bampton P, Andrews J, Fraser R, Mukherjee S, et al.
JGH Open . 2023 Mar; 7(3):190-196. PMID: 36968569
Background And Aim: Inflammatory bowel disease (IBD) can disrupt sleep, leading to poor sleep quality. This may in part be due to the symptoms of IBD and the influence of...
12.
Wassie M, Young G, Winter J, Cock C, Bampton P, Rahman M, et al.
Clin Gastroenterol Hepatol . 2023 Jan; 21(9):2389-2398.e2. PMID: 36610499
Background & Aims: In above-average-risk individuals undergoing colonoscopy-based surveillance for colorectal cancer (CRC), screening with fecal immunochemical tests (FIT) between colonoscopies might facilitate personalization of surveillance intervals. Because a negative...
13.
Barnes A, Mountifield R, Baker J, Spizzo P, Bampton P, Mukherjee S
JGH Open . 2022 Nov; 6(11):738-744. PMID: 36406652
Poor sleep in people with inflammatory bowel disease (IBD) has been demonstrated to be prevalent and has been associated with disease activity. This meta-analysis aimed to assess the prevalence of...
14.
Barnes A, Ooi S, Lynch K, Parthasarathy N, Bishara M, Gounder M, et al.
Dig Dis Sci . 2022 Jun; 68(3):889-896. PMID: 35687221
Background: The thiopurine medications are well established in the treatment of inflammatory bowel disease (IBD). There is significant variation in levels of toxic and therapeutic metabolites. Current data from small...
15.
Wassie M, Young G, Cock C, Bampton P, Winter J, Simpson K, et al.
J Gastroenterol Hepatol . 2022 Mar; 37(6):1067-1075. PMID: 35261071
Background And Aim: Surveillance colonoscopies may be delayed because of pressure on resources, such as the COVID-19 pandemic. This study aimed to determine whether delayed surveillance colonoscopy increases the risk...
16.
Jaenisch S, Abbott C, Gorrell M, Bampton P, Butler R, Yazbeck R
Clin Transl Gastroenterol . 2022 Jan; 13(1):e00452. PMID: 35060938
Introduction: Dipeptidyl peptidase (DPP)-4 is part of a larger family of proteases referred to as DPPs. DPP4 has been suggested as a possible biomarker for inflammatory bowel disease (IBD). Circulating...
17.
Wassie M, Agaciak M, Cock C, Bampton P, Young G, Symonds E
JGH Open . 2021 Apr; 5(4):486-492. PMID: 33869788
Background And Aim: The coronavirus disease 2019 (COVID-19) global pandemic has affected elective procedures, including colonoscopy, worldwide. Delayed colorectal cancer surveillance may increase cancer risk. This study aimed to determine...
18.
Anwar S, Cock C, Young J, Young G, Meng R, Simpson K, et al.
J Gastroenterol Hepatol . 2020 Nov; 36(6):1620-1626. PMID: 33140867
Background And Aim: Clinically significant serrated polyps are precursors of colorectal cancers, with features considered high risk including size ≥10 mm, dysplasia, and presence of synchronous conventional adenoma. While these...
19.
Pulusu S, Srinivasan A, Krishnaprasad K, Cheng D, Begun J, Keung C, et al.
World J Gastroenterol . 2020 Sep; 26(30):4428-4441. PMID: 32874055
Background: Vedolizumab (VDZ), a humanised monoclonal antibody that selectively inhibits integrins is approved for use in adult moderate to severe ulcerative colitis (UC) patients. Aim: To assess the efficacy and...
20.
Julsgaard M, Hvas C, Gearry R, Gibson P, Fallingborg J, Sparrow M, et al.
Inflamm Bowel Dis . 2019 May; 26(1):93-102. PMID: 31141607
Background: Active inflammatory bowel disease (IBD) adversely affects pregnancy outcomes. Little is known about the risk of relapse after stopping anti-tumor necrosis factor (anti-TNF) treatment during pregnancy. We assessed the...